Skip to main content
SpringerLink
Log in
Springer

Experimental and Computational Multiphase Flow - Call for Papers: Special Issue on Advancements in Aerosol Drug Delivery for Inhalation Therapy

Inhalation therapy plays a pivotal role in treating a diverse range of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, sinus congestion, and post-surgery care following functional endoscopic sinus surgery (FESS), etc. In recent years, there has also been a surge in research attention towards olfactory-targeted aerosol delivery, presenting a promising pathway for tackling central nervous system disorders, including conditions like Alzheimer’s disease. Although numerous of treatment options and products are accessible, the efficacy of aerosol delivery remains constrained by the intricate interplay between release conditions and the complex airway geometry, as well as airflow dynamics, particularly when considering distinct target regions or patients from diverse age groups.

This intricate interplay poses a significant challenge, impacting both the effectiveness of aerosolised medications and the potential for unintended side effects due to overexposure in non-targeted regions. As such, there is a pressing need to delve deeper into optimising aerosol delivery performance, unravelling the complexities of airway dynamics, and refining targeting strategies. This call for a special issue seeks to gather cutting-edge research that addresses these challenges and advances our understanding of inhalation therapy, aerosol dynamics, and targeted drug aerosol delivery mechanisms. We welcome contributions from researchers, clinicians, and experts in the field to shed light on novel approaches, technological innovations, and tailored treatment strategies that hold the promise of enhancing the precision and impact of inhalation-based treatments.


Potential topics for submission to this special issue may include, but are not limited to:

  • Advanced aerosol generation techniques and devices
  • Computational modelling of airflow and particle deposition in the respiratory tract
  • Innovative in vitro and in vivo experiments for evaluating aerosol delivery efficiency
  • Mechanistic insights into aerosol-patient interactions and deposition patterns

By fostering a comprehensive dialogue on these critical issues, this special issue aims to accelerate the development of next-generation inhalation therapies, ultimately offering patients a more precise and effective means of managing respiratory and neurological conditions. We encourage researchers to submit their original research, reviews, and perspectives to contribute to this timely and impactful collection of articles, driving the field of inhalation therapy forward into a new era of therapeutic possibilities.

SUBMISSION GUIDELINES

For authors who want to submit manuscripts to our Special Issue, please first refer to the “Instructions for Authors” on the journal homepage to know the handling procedures and quality standards of the Journal. Prospective authors should submit an electronic copy of their completed manuscript to https://mc03.manuscriptcentral.com/ecmf (this opens in a new tab) with “Special Issue on Inhalation Drug Delivery” marked in the cover letter section. Further information about the journal is available at https://www.springer.com/journal/42757 (this opens in a new tab).

IMPORTANT DATE

Manuscript Due:  July 31, 2024

GUEST EDITORS

Dr. Jingliang Dong
Lecturer, ARC DECRA Fellow, Victoria University, Australia
E-mail: Jingliang.dong@vu.edu.au (this opens in a new tab)

Dr. Jinxiang Xi
Associate Professor, University of Massachusetts Lowell, USA
E-mail: Jinxiang_Xi@uml.edu (this opens in a new tab)


Search

Navigation